The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

However, as with the introduction of any antibiotic, early results should not be overhyped. Writing in Nature, Jangra et al. 1 present a satisfyingly complete account of the discovery and initial ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The 2025 MG 4 EV has got a few changes in dimensions and the overall design MG has taken over the electric vehicle market in China and is now heading towards a global influence with the MG 4 EV ...

The MGS5 EV takes the brand’s electric SUV range to new heights thanks to its combination of space, standard equipment and range. It also feels appropriately tuned for UK roads and is surprising ...

2-Year U.S. Treasury Note Continuous Contract $103.586 0.172 0.17% 5-Year U.S. Treasury Note Continuous Contract $108.188 0.516 0.48% 10-Year U.S. Treasury Note Continuous Contract $111.219 0.797 ...

Paid non-client promotion: Affiliate links for the products on this page are from partners that compensate us (see our advertiser disclosure with our list of partners for more details). However ...

A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time in decades. It’s an oral pill called Blujepa from the London-based biopharma ...

At close: March 28 at 3:12:17 p.m. EDT Loading Chart for MOX.V ...

Warner Bros. Discovery Inc. Series A $10.37-0.64-5.81% ...